METOCLOPRAMIDE INDUCED GROWTH HORMONE RELEASE IN HYPOGONADAL MALES

H. N. COHEN, I. D. HAY, G. H. BEASTALL, J. A. THOMSON

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The growth hormone (GH) response to 10 mg intravenous metoclopramide (MCP) (‘Maxo1on’‐Beecham Laboratories) was determined in ten hypogonadal adult males. All the subjects responded with a peak growth hormone level > 14 mU/1 within 1 hour of administration of MCP. Seven normal adult males did not respond to MCP administration. It is concluded that MCP stimulation may be a useful test for both prolactin and growth hormone reserve in hypogonadal males.

Original languageEnglish (US)
Pages (from-to)95-97
Number of pages3
JournalClinical Endocrinology
Volume11
Issue number1
DOIs
StatePublished - Jul 1979

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'METOCLOPRAMIDE INDUCED GROWTH HORMONE RELEASE IN HYPOGONADAL MALES'. Together they form a unique fingerprint.

Cite this